MedPath

Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure

Not Applicable
Completed
Conditions
Chronic Heart Failure
Registration Number
NCT01692119
Lead Sponsor
Federal Union of German Associations of Pharmacists
Brief Summary

The aim of the study is to investigate whether a continuous interdisciplinary intervention improves medication adherence (primary efficacy endpoint) and leads to a reduction of hospitalizations and mortality (primary safety endpoint) in elderly patients with chronic heart failure. The intervention, consisting of regular contacts with the local pharmacy and weekly dosing aids, aims to improve medication adherence and management.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
258
Inclusion Criteria
  • Age: 60 years and older
  • Chronic heart failure (CHF)
  • Stable CHF medication including a diuretic
  • Hospitalization for decompensated heart failure within past 12 months OR a value of ≥ 350 pg/mL for BNP or ≥ 1,400 pg/mL for NT-proBNP
  • Written informed consent
Exclusion Criteria
  • Use of a weekly dosing aid
  • Unwillingness or inability to visit a participating pharmacy once a week
  • Planned cardiac surgery
  • Life-expectancy < 6 months
  • Unwillingness or inability to comply with the study protocol (including drug abuse or alcohol dependency)
  • Participation in other studies (currently or in the last 4 weeks)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Medication Adherence12 months

Percentage of days covered (PDC) by prescribed medication and according to claims data

Days Lost Due to Unplanned Cardiovascular Hospitalizations or Death of Any Cause12 months

Days lost due to unplanned cardiovascular hospitalizations or death of any cause

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saarland University

🇩🇪

Homburg/Saar, Germany

Saarland University
🇩🇪Homburg/Saar, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.